Latest News

- SARS-CoV-2: New Findings on the Persistence of Neutralizing Antibodies

Symbol image shows antibodies and coronaviruses.

Data from the “Rhineland Study” in Bonn, Germany.

Read more

- Experimental gene regulation therapy lowers levels of Tau protein in the brain and could protect against Alzheimer's

Symbolic image of a nerve cell.

A research group involving the DZNE has successfully developed a new method of gene regulation that permanently reduces the protein "tau" in the adult brain. This could become the basis for new therapies against Alzheimer's and other neurodegenerative diseases.

Read more

- DZNE’s First Spin-off “Neuron–D” Uses Innovative Technology for Drug Testing

his microscopic image shows networks of neurons as they typically develop in 3D cell cultures.

Drug screening with 3D cell cultures.

Read more

- DZNE and Eisai Enter Into Research Collaboration Agreement

Logo Eisai

The DZNE and Eisai Co., Ltd. announce that both parties have entered into a research collaboration agreement aiming to create potential novel treatments for neurodegenerative disorders.

Read more

- A weak heart makes a suffering brain

The decorative image shows a network-like connection between the brain and the heart.

Evidence of Disturbed Gene Activity in the Brain as a Result of Heart Problems.

Read more

- „Fat Jam“ in the Cell

A microscopic view on microglia reveals disturbances in how these phagocytic cells, which belong to the brain’s immune system, cope with inhaled material.

New insights into the rare brain disease “Niemann-Pick type C”.

Read more

- COVID-19 Has Multiple Faces

Graphic representation of the coronavirus.

According to current studies, the COVID-19 disease which is caused by the SARS-CoV-2 coronavirus comprises at least five different variants. Researchers from the DZNE and the University of Bonn report on this in the scientific journal “Genome Medicine”.

Read more

- DZNE and Aparito develop mobile app to assess ataxia symptoms at home

Visualisation for using the app.

A new app will now allow people with ataxia to assess the severity of their disease at home. It is based on the well-known SARA score, which DZNE researchers have now been able to bring into use outside of clinics.

Read more

- New European alliance formed to tackle urgent challenge of neurodegenerative diseases


The DZNE is a founding member of CURE-ND, a cluster of European research institutions that aim to jointly address the challenge of neurodegenerative diseases.

Read more

- ERC Grant for DZNE Researcher

ERC signet

Michela Deleidi, a Parkinson’s researcher at the DZNE’s Tübingen site, has been awarded a “Consolidator Grant” of the European Research Council worth about two million euros.

Read more


Thursdays 1:30-4:30 pm

Patients +49 800-7799001

(free of charge)

Professionals +49 180-779900

(9 Cent/Min. German landline, mobile and out of Germany possibly more expensive)

Welcome to our website, here you can inform yourself basically cookie-free.

We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.

Your browser allows the setting of cookies: